@article{5b4a6efaebb5414c96c8666a362495a4,
title = "The first prospective trial for von Hippel-Lindau disease: pazopanib",
keywords = "Journal Article, Pyrimidines, Prospective Studies, Sulfonamides, Humans, von Hippel-Lindau Disease",
author = "Giles, \{Rachel H\} and Sven Gl{\"a}sker",
note = "Funding Information: RHG reports voluntary work for the International Kidney Cancer Coalition and receives unrestricted educational grants from Novartis, Roche, Pfizer, BMS, Eisai, Merck MSD, Ipsen, and Exelixis. SG declares no competing interests.",
year = "2018",
month = oct,
doi = "10.1016/S1470-2045(18)30533-3",
language = "English",
volume = "19",
pages = "1267--1269",
journal = "LANCET ONCOLOGY",
issn = "1470-2045",
publisher = "Elsevier Limited",
number = "10",
}